|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR |
1 Department of Physiology, The Medical School, University of Birmingham, Birmingham B15 2TT, UK
Abstract
Adenosine and nitric oxide (NO) are important local mediators of vasodilatation. The aim of this study was to elucidate the mechanisms underlying adenosine receptor-mediated NO release from the endothelium. In studies on freshly excised rat aorta, second-messenger systems were pharmacologically modulated by appropriate antagonists while a NO-sensitive electrode was used to measure adenosine-evoked NO release from the endothelium. We showed that A1-mediated NO release requires extracellular Ca2+, phospholipase A2 (PLA2) and ATP-sensitive K+ (KATP) channel activation whereas A2A-mediated NO release requires extracellular Ca2+ and Ca2+-activated K+ (KCa) channels. Since our previous study showed that A1- and A2A-receptor-mediated NO release requires activation of adenylate cyclase (AC), we propose the following novel pathways. The K+ efflux resulting from A1-receptor-coupled KATP-channel activation facilitates Ca2+ influx which may cause some stimulation of endothelial NO synthase (eNOS). However, the increase in [Ca2+]i also stimulates PLA2 to liberate arachidonic acid and stimulate cyclooxygenase to generate prostacyclin (PGI2). PGI2 acts on its endothelial receptors to increase cAMP, so activating protein kinase A (PKA) to phosphorylate and activate eNOS resulting in NO release. By contrast, the K+ efflux resulting from A2A-coupled KCa channels facilitates Ca2+ influx, thereby activating eNOS and NO release. This process may be facilitated by phosphorylation of eNOS by PKA via the action of A2A-receptor-mediated stimulation of AC increasing cAMP. These pathways may be important in mediating vasodilatation during exercise and systemic hypoxia when adenosine acting in an endothelium- and NO-dependent manner has been shown to be important.
(Received 25 July 2005;
accepted after revision 18 October 2005;
first published online 20 October 2005)
Corresponding author C. J. Ray: Department of Physiology, The Medical School, University of Birmingham, Birmingham B15 2TT, UK. Email: c.j.ray{at}bham.ac.uk
This article has been cited by other articles:
![]() |
K.-T. Cheng, Y.-K. Leung, B. Shen, Y.-C. Kwok, C.-O. Wong, H.-Y. Kwan, Y.-B. Man, X. Ma, Y. Huang, and X. Yao CNGA2 Channels Mediate Adenosine-Induced Ca2+ Influx in Vascular Endothelial Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 913 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Merla, Y. Ye, Y. Lin, S. Manickavasagam, M.-H. Huang, R. J. Perez-Polo, B. F. Uretsky, and Y. Birnbaum The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1918 - H1928. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Winter and K. A. Dora Spreading dilatation to luminal perfusion of ATP and UTP in rat isolated small mesenteric arteries J. Physiol., July 1, 2007; 582(1): 335 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cappello, T. Angelone, B. Tota, P. Pagliaro, C. Penna, R. Rastaldo, A. Corti, G. Losano, and M. C. Cerra Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H719 - H727. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Ibe, A. Ameer, A. M. Portugal, L. Renteria, and J. U. Raj Platelet-Activating Factor Modulates Activity of Cyclic Nucleotides in Fetal Ovine Pulmonary Vascular Smooth Muscle J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 728 - 737. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |